[
  {
    "question": "Child with developmental delay and EEG showed hypsarrhythmia what is the diagnosis:",
    "option_a": "West syndrome",
    "option_b": "Lennox-Gastaut syndrome",
    "option_c": "Juvenile Myoclonic Epilepsy",
    "option_d": "Aicardi syndrome",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "West syndrome is an epileptic encephalopathy of infancy characterized by a clinical triad of infantile spasms, developmental delay or regression, and a distinct chaotic EEG pattern known as hypsarrhythmia. The abnormal brain development in West syndrome leads to disorganized and high-amplitude EEG activity (hypsarrhythmia). This disorder can be due to a range of etiologies including structural, metabolic, and genetic causes, which disrupt normal cortical organization. Clinically, affected children present with developmental delays and clusters of brief spasms, typically starting in the first year of life. The EEG pattern of hypsarrhythmia is diagnostic and helps differentiate West syndrome from other pediatric epilepsies. Diagnosis is made based on clinical presentation and EEG findings. Differential diagnoses include Lennox-Gastaut syndrome (which usually presents later with slow spike-wave discharges), Juvenile Myoclonic Epilepsy (adolescent onset with myoclonic jerks), and Aicardi syndrome (a rare condition with a broader spectrum of neurological and ocular abnormalities). First-line treatment for West syndrome includes hormonal therapy (adrenocorticotropic hormone [ACTH] or oral corticosteroids) and vigabatrin, particularly in cases with evidence of tuberous sclerosis. Early intervention is crucial for improving developmental outcomes. Although pregnancy and lactation are not directly relevant to typical West syndrome patients, medication safety during breastfeeding is a consideration in infant management, and careful dosing/monitoring is required. Option A (West syndrome) is correct because the combination of developmental delay and the classic EEG pattern of hypsarrhythmia is diagnostic. Option B (Lennox-Gastaut syndrome) typically presents in later childhood with a different EEG pattern (slow spike-wave discharges). Option C (Juvenile Myoclonic Epilepsy) is characterized by myoclonic jerks in adolescence and a different EEG pattern. Option D (Aicardi syndrome) has specific features such as agenesis of the corpus callosum and chorioretinal lacunae and is less common. \u2022 Hypsarrhythmia on EEG is a hallmark of West syndrome. \u2022 Early treatment is crucial to prevent further developmental regression. \u2022 West syndrome typically presents in the first year of life with infantile spasms. Recent guideline updates emphasize early diagnosis and aggressive treatment with ACTH or vigabatrin to improve neurodevelopmental outcomes in West syndrome. Ongoing research is exploring the long-term cognitive and developmental benefits of early therapeutic intervention.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Characteristic of temporal lobe epilepsy:",
    "option_a": "Ipsilateral nose rubbing",
    "option_b": "Asymmetric tonic limb posturing",
    "option_c": "Prolonged post ictal",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Temporal lobe epilepsy (TLE) is a common type of focal epilepsy where seizures originate within the temporal lobe. These seizures often feature automatisms \u2013 involuntary, repeated motor behaviors \u2013 such as ipsilateral nose rubbing, lip smacking, or picking at clothing. In TLE, abnormal electrical discharges typically begin in medial temporal structures, including the hippocampus, amygdala, and entorhinal cortex. These discharges spread to adjacent neural networks involved in motor and behavioral functions, leading to stereotyped automatisms. The involvement of limbic structures also explains the affective and experiential phenomena observed during seizures. Patients with TLE may display subtle motor behaviors during a seizure. Ipsilateral nose rubbing is one such automatism that reflects involvement of neural circuits controlling orofacial motor functions. Recognizing such specific behaviors helps in localizing the seizure onset to the temporal lobe. Diagnosis of TLE involves a detailed clinical history and video EEG monitoring to capture the stereotyped automatisms. MRI is used to assess for structural abnormalities (e.g., mesial temporal sclerosis). Differential diagnoses include frontal lobe epilepsy (which may have hypermotor features) and psychogenic non\u2010epileptic seizures, which lack the stereotypy seen in TLE. First\u2010line treatment for TLE usually consists of antiepileptic drugs (AEDs) such as Carbamazepine, Oxcarbazepine, or Levetiracetam. In cases of drug\u2010resistant TLE, surgical resection of the epileptogenic focus may be considered. For pregnant and lactating patients, AED choice must balance seizure control with teratogenic risk (e.g., lamotrigine is often preferred) and breastfeeding safety. Option A (Ipsilateral nose rubbing) is a classic ictal automatism seen in TLE. Option B (Asymmetric tonic limb posturing) is more typically observed in seizures with motor involvement from other lobes (such as frontal lobe seizures). Option C (Prolonged postictal state) is more characteristic of generalized seizures and is not specific for TLE. 1. TLE frequently presents with subtle automatisms like nose rubbing. 2. Mesial temporal structures (hippocampus/amygdala) are classically implicated. 3. Accurate seizure semiology substantially aids in localizing the epileptogenic focus. Recent studies emphasize the role of detailed video-EEG monitoring for seizure localization in TLE. Updated guidelines support surgical evaluation in drug-resistant cases and stress careful AED selection in women of childbearing age to minimize teratogenic effects.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "bus driver has a seizure and tells you not to tell his employer about the seizure, what will you do?",
    "option_a": "tell him you have to inform his employer",
    "option_b": "You inform the employer",
    "option_c": "tell him OK I will not inform the employer",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Temporal lobe epilepsy (TLE) is a common type of focal epilepsy where seizures originate within the temporal lobe. These seizures often feature automatisms \u2013 involuntary, repeated motor behaviors \u2013 such as ipsilateral nose rubbing, lip smacking, or picking at clothing. In TLE, abnormal electrical discharges typically begin in medial temporal structures, including the hippocampus, amygdala, and entorhinal cortex. These discharges spread to adjacent neural networks involved in motor and behavioral functions, leading to stereotyped automatisms. The involvement of limbic structures also explains the affective and experiential phenomena observed during seizures. Patients with TLE may display subtle motor behaviors during a seizure. Ipsilateral nose rubbing is one such automatism that reflects involvement of neural circuits controlling orofacial motor functions. Recognizing such specific behaviors helps in localizing the seizure onset to the temporal lobe. Diagnosis of TLE involves a detailed clinical history and video EEG monitoring to capture the stereotyped automatisms. MRI is used to assess for structural abnormalities (e.g., mesial temporal sclerosis). Differential diagnoses include frontal lobe epilepsy (which may have hypermotor features) and psychogenic non\u2010epileptic seizures, which lack the stereotypy seen in TLE. First\u2010line treatment for TLE usually consists of antiepileptic drugs (AEDs) such as Carbamazepine, Oxcarbazepine, or Levetiracetam. In cases of drug\u2010resistant TLE, surgical resection of the epileptogenic focus may be considered. For pregnant and lactating patients, AED choice must balance seizure control with teratogenic risk (e.g., lamotrigine is often preferred) and breastfeeding safety. Option A (Ipsilateral nose rubbing) is a classic ictal automatism seen in TLE. Option B (Asymmetric tonic limb posturing) is more typically observed in seizures with motor involvement from other lobes (such as frontal lobe seizures). Option C (Prolonged postictal state) is more characteristic of generalized seizures and is not specific for TLE. 1. TLE frequently presents with subtle automatisms like nose rubbing. 2. Mesial temporal structures (hippocampus/amygdala) are classically implicated. 3. Accurate seizure semiology substantially aids in localizing the epileptogenic focus. Recent studies emphasize the role of detailed video-EEG monitoring for seizure localization in TLE. Updated guidelines support surgical evaluation in drug-resistant cases and stress careful AED selection in women of childbearing age to minimize teratogenic effects.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "First time seizure with normal imaging and EEG, what is the risk of recurrence?",
    "option_a": "If the seizures were deemed idiopathic, only 17% had a recurrence at 20 months, rising to 26% by 36 months.",
    "option_b": "If the seizures were idiopathic with spike-wave discharges on EEG, however, the risk of seizure recurrence was 50% at 18 months.",
    "option_c": "If the seizure was idiopathic and the patient had a sibling with seizures, the risk of seizure recurrence was 29% at 4 months.",
    "option_d": "In patients with head trauma, who comprised 37% of the remote symptomatic group, the recurrence risk was 40% at 12 months and 46% at 20 months.",
    "option_e": "30%",
    "correct_answer": "E",
    "subspecialty": "Epilepsy",
    "explanation": "Temporal lobe epilepsy (TLE) is a common type of focal epilepsy where seizures originate within the temporal lobe. These seizures often feature automatisms \u2013 involuntary, repeated motor behaviors \u2013 such as ipsilateral nose rubbing, lip smacking, or picking at clothing. In TLE, abnormal electrical discharges typically begin in medial temporal structures, including the hippocampus, amygdala, and entorhinal cortex. These discharges spread to adjacent neural networks involved in motor and behavioral functions, leading to stereotyped automatisms. The involvement of limbic structures also explains the affective and experiential phenomena observed during seizures. Patients with TLE may display subtle motor behaviors during a seizure. Ipsilateral nose rubbing is one such automatism that reflects involvement of neural circuits controlling orofacial motor functions. Recognizing such specific behaviors helps in localizing the seizure onset to the temporal lobe. Diagnosis of TLE involves a detailed clinical history and video EEG monitoring to capture the stereotyped automatisms. MRI is used to assess for structural abnormalities (e.g., mesial temporal sclerosis). Differential diagnoses include frontal lobe epilepsy (which may have hypermotor features) and psychogenic non\u2010epileptic seizures, which lack the stereotypy seen in TLE. First\u2010line treatment for TLE usually consists of antiepileptic drugs (AEDs) such as Carbamazepine, Oxcarbazepine, or Levetiracetam. In cases of drug\u2010resistant TLE, surgical resection of the epileptogenic focus may be considered. For pregnant and lactating patients, AED choice must balance seizure control with teratogenic risk (e.g., lamotrigine is often preferred) and breastfeeding safety. Option A (Ipsilateral nose rubbing) is a classic ictal automatism seen in TLE. Option B (Asymmetric tonic limb posturing) is more typically observed in seizures with motor involvement from other lobes (such as frontal lobe seizures). Option C (Prolonged postictal state) is more characteristic of generalized seizures and is not specific for TLE. 1. TLE frequently presents with subtle automatisms like nose rubbing. 2. Mesial temporal structures (hippocampus/amygdala) are classically implicated. 3. Accurate seizure semiology substantially aids in localizing the epileptogenic focus. Recent studies emphasize the role of detailed video-EEG monitoring for seizure localization in TLE. Updated guidelines support surgical evaluation in drug-resistant cases and stress careful AED selection in women of childbearing age to minimize teratogenic effects.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Localization of palpitation in seizure attacks?",
    "option_a": "Amygdala",
    "option_b": "Insula??",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Palpitations during seizure attacks are a manifestation of autonomic dysfunction. The insular cortex plays a central role in integrating visceral sensory information and modulating the autonomic nervous system. Its activation during seizures can lead to cardiovascular symptoms, such as tachycardia and the sensation of a pounding heart. The insula is involved in the regulation of both sympathetic and parasympathetic output. Seizure activity involving the insular cortex can cause an imbalance in autonomic control, leading to an exaggerated sympathetic response. This can manifest clinically as palpitations, as the heart rate increases abruptly during an insular seizure. Patients with seizures that produce prominent autonomic symptoms, including palpitations, often have insular involvement. Neuroimaging and intracranial EEG studies in some cases of focal epilepsy have demonstrated that electrical stimulation of the insular region can reproduce autonomic signs. This helps clinicians localize the epileptogenic zone, particularly in cases with prominent cardiovascular symptoms. The evaluation of autonomic symptoms in epilepsy includes detailed clinical history, electroencephalography (EEG), and neuroimaging (MRI, sometimes PET) to identify the focal origin of seizures. When patients report palpitations correlated with seizure events, it is important to consider an insular focus. Cardiac monitoring during EEG recordings can provide supporting evidence by demonstrating concomitant tachycardia. Management of focal seizures with insular involvement is similar to that of other focal epilepsies and typically includes the use of appropriate antiepileptic drugs (AEDs). Special considerations are needed in pregnant patients where drugs like lamotrigine or levetiracetam, which have more favorable teratogenic profiles, are preferred over agents like valproate. Additionally, folate supplementation is recommended in pregnancy. For lactating women, AEDs should be chosen with attention to milk transfer and neonatal effects, and mothers should receive counseling on breastfeeding safety. Option A (Amygdala) is known for its role in emotional and fear responses, though it also modulates autonomic function. However, the insula (Option B) has a more direct role in cardiovascular autonomic regulation, making it the most likely locus for palpitation symptoms during seizures. The marked answer (B: Insula) aligns with current evidence linking insular activation to autonomic manifestations. \u2022 Autonomic symptoms during seizures, such as palpitations, warrant an evaluation of the insular cortex as a possible epileptogenic focus.  \u2022 EEG and advanced neuroimaging are key in localizing the seizure focus.  \u2022 In managing epileptic patients with autonomic symptoms, careful selection of antiepileptic drugs is necessary, especially in pregnant and lactating women to minimize maternal and fetal risks. Recent research has reinforced the role of the insular cortex in autonomic regulation and has demonstrated that stimulation of the insula can precipitate cardiovascular changes, including tachycardia. These findings support the localization of palpitation symptoms to the insula during seizures and have been integrated into current clinical practice guidelines, which also stress the importance of adjusting management strategies in special populations such as pregnant and lactating women.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "What is the AED that has the highest concentration in breast milk?",
    "option_a": "Carbamazepine",
    "option_b": "Valproate",
    "option_c": "Levetiracetam",
    "option_d": "Phenobarbital",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Epilepsy",
    "explanation": "This question addresses the pharmacokinetic property of antiepileptic drugs (AEDs) regarding their transfer into breast milk\u2014a crucial consideration when treating lactating mothers with epilepsy. The core concept is that drugs with low protein binding and high water solubility tend to be secreted into breast milk in higher concentrations. The amount of an AED found in breast milk depends on its molecular characteristics such as lipophilicity, molecular weight, and especially protein binding. Levetiracetam, which has minimal protein binding, is less retained in the maternal circulation and can cross into milk more readily. Although phenobarbital is also known to cross into breast milk, its pharmacokinetic profile (including a longer half\u2010life and greater protein binding variability) usually does not result in as high a concentration relative to maternal serum when compared to levetiracetam under typical dosing regimens. Clinically, higher concentrations of an AED in breast milk can result in greater neonatal exposure. However, for levetiracetam, despite a relatively high milk-to-plasma ratio, the infant\u2019s serum levels remain low due to rapid clearance, making it acceptable for use during lactation. This information is essential when counseling breastfeeding mothers with epilepsy about the safety of their medication. While not a diagnostic test per se, understanding drug transfer into breast milk involves reviewing pharmacologic properties, lactation studies, and drug-specific databases (e.g., LactMed). Differential considerations include other AEDs such as carbamazepine and valproate, which have lower milk-to-plasma ratios, and phenobarbital, which, despite its transfer, does not usually reach the highest concentrations relative to levetiracetam in routine clinical practice. Current guidelines recommend that when managing epilepsy in breastfeeding mothers, drugs with a favorable lactation profile be selected. First-line management often involves using AEDs such as levetiracetam or lamotrigine because of their relatively safe profiles in both pregnancy and lactation. For mothers who are pregnant or lactating, it is important to monitor both maternal seizure control and the infant for any potential adverse effects, though levetiracetam is considered safe at therapeutic doses. Option A (Carbamazepine) and Option B (Valproate) have lower milk-to-plasma ratios compared to levetiracetam. Option D (Phenobarbital) is known to cross into breast milk significantly, but pharmacokinetic studies generally show that levetiracetam, due to its minimal protein binding and rapid transfer, reaches higher concentrations relative to maternal serum. Thus, Option C (Levetiracetam) is the most correct answer. 1. Levetiracetam exhibits minimal protein binding, leading to higher transfer into breast milk, but the infant clearance maintains low serum levels. 2. Counseling breastfeeding mothers involves a risk\u2010benefit analysis that includes reviewing the lactation safety profiles of AEDs. 3. Regular monitoring of both maternal and infant drug levels is recommended where appropriate. Recent studies and reviews, including data from lactation databases and guidelines from epilepsy and neurology societies, support the use of levetiracetam in breastfeeding mothers due to its predictable pharmacokinetics and overall safety profile. Ongoing research continues to refine recommendations to optimize maternal seizure control while minimizing infant exposure.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "AED cause fingers/toes dysthesia",
    "option_a": "Topiramate",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "This question focuses on the side effect profile of AEDs, specifically highlighting an uncommon effect manifested as dysthesia in the fingers and toes. Understanding the neurotoxic and metabolic effects of AEDs is central to proper drug choice and management of adverse effects. Topiramate is known to inhibit carbonic anhydrase, which can lead to alterations in acid\u2013base balance and disturbances in neuronal excitability. This inhibition is believed to contribute to the development of peripheral paresthesias and dysesthesias. The abnormal sensations are thought to result from altered ion channel function and micro-environmental changes in peripheral nerves. Patients on topiramate may report tingling, numbness, or \u2018pins and needles\u2019 sensations in their extremities, particularly affecting the fingers and toes. These sensory side effects are typically dose-related and may improve with dose adjustment or discontinuation of therapy. The differential diagnosis for dysthesia includes metabolic disturbances (such as hypocalcemia or vitamin B12 deficiency), peripheral neuropathy, and other medication-induced neuropathies. A careful review of the medication history and linked temporal relationship is key to differentiating topiramate-induced dysesthesia from other causes. First-line management involves dose reduction or switching to another AED if the dysesthesias become bothersome. In pregnant patients, topiramate is associated with an increased risk for cleft lip/palate, and its use requires careful evaluation against the risk of uncontrolled seizures. During lactation, while topiramate is excreted in breast milk, the clinical impact on the infant is generally minimal but should be monitored. If adverse effects occur, adjusting the dose and regular monitoring of both maternal and infant clinical status are recommended. Option A (Topiramate) is the correct answer as it is well-known to cause peripheral dysesthesias due to its carbonic anhydrase inhibition. Other AEDs, which are not listed, generally do not exhibit this side effect profile to the same extent. 1. Topiramate\u2019s side effects, including paresthesias in the extremities, are dose-dependent and often reversible. 2. The carbonic anhydrase inhibition from topiramate can also predispose patients to metabolic acidosis. 3. In pregnancy, topiramate use requires caution due to an increased risk of congenital malformations. Recent guidelines emphasize individualized treatment planning for women of childbearing potential. Studies have reinforced that while topiramate is effective, its metabolic side effects necessitate careful dose management and monitoring, especially during pregnancy and lactation.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Scenario of dyscognitive auras (Temporal lobe epilepsy TLE) MRI for mtle",
    "option_a": "",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "Mesial temporal sclerosis \u2013 the option describing ipsilateral hippocampal atrophy with increased T2/FLAIR signal on MRI",
    "subspecialty": "Epilepsy",
    "explanation": "This question examines the imaging characteristics in patients with temporal lobe epilepsy (TLE) presenting with dyscognitive auras. The focus is on mesial temporal lobe epilepsy (MTLE), where the classic finding is mesial temporal sclerosis (MTS) identifiable via MRI. Mesial temporal sclerosis involves neuronal loss and gliosis in the hippocampus, leading to atrophy and a characteristic increased T2/FLAIR signal on MRI. This structural abnormality is key in the pathogenesis of MTLE, likely resulting from an injury or prolonged seizure activity that damages mesial temporal structures. Patients with MTLE typically experience auras characterized by altered awareness (dyscognitive auras), followed by complex partial seizures. The detection of hippocampal sclerosis on MRI strongly supports the diagnosis and correlates with the clinical localization of seizure onset. Diagnosis involves a combination of detailed clinical history, video-EEG monitoring, and high-resolution MRI. Differential diagnoses include neocortical temporal lesions, non-specific white matter changes, extratemporal epilepsy, or normal MRI findings in some epilepsy syndromes. The classic finding of unilateral hippocampal atrophy with increased T2/FLAIR signal is highly suggestive of MTS. First-line management of MTLE involves AED therapy (e.g., levetiracetam, carbamazepine), with the choice guided by seizure type and patient-specific factors. For drug-resistant cases, surgical resection (temporal lobectomy) is considered. During pregnancy, maintaining seizure control is critical, and drugs with safer profiles in pregnancy and lactation should be used; options may include levetiracetam or lamotrigine after careful risk\u2010benefit analysis. The marked answer correctly identifies mesial temporal sclerosis\u2014specifically, the MRI finding of ipsilateral hippocampal atrophy with increased T2/FLAIR signal\u2014which is the hallmark imaging feature in most cases of MTLE. Other options (if provided) that do not include this description would not be appropriate. 1. Hippocampal sclerosis on MRI is the signature finding in MTLE, correlating with mesial temporal dysfunction. 2. The presence of dyscognitive auras in TLE should prompt a high-resolution MRI to evaluate for MTS. 3. Even if the MRI is normal, MTLE cannot be entirely ruled out, but the likelihood is lower. Recent advances in neuroimaging have enhanced the sensitivity of MRI in detecting subtle mesial temporal changes. Current guidelines advocate for high-resolution, 3T MRI protocols in suspected MTLE cases, and there is robust evidence supporting early surgical intervention in drug-resistant cases to improve outcomes.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Scenario about Rolandic epilepsy, what is the EEG findings",
    "option_a": "",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "Centrotemporal (rolandic) spikes \u2013 the option describing high\u2010amplitude centrotemporal sharp waves, especially during sleep",
    "subspecialty": "Epilepsy",
    "explanation": "This question focuses on the electroencephalogram (EEG) findings characteristic of Rolandic epilepsy, also known as benign childhood epilepsy with centrotemporal spikes (BCECTS). Recognizing the EEG pattern is vital for diagnosing this common pediatric epilepsy syndrome. Rolandic epilepsy is an idiopathic focal epilepsy syndrome that involves the centrotemporal (rolandic) region of the brain. The underlying mechanism is believed to be linked to developmental factors rather than acquired brain pathology. The hallmark EEG finding is high-amplitude, sharply contoured centrotemporal spikes that are often accentuated during non-rapid eye movement (non-REM) sleep. Children with Rolandic epilepsy typically present with seizures that may involve facial twitching and hypersalivation, primarily during sleep. The EEG abnormality\u2014centrotemporal spikes\u2014correlates well with the clinical manifestations and usually confirms the diagnosis. The diagnostic approach in suspected Rolandic epilepsy includes a thorough clinical evaluation and EEG. Differential diagnoses would include other childhood epilepsy syndromes such as childhood absence epilepsy (characterized by generalized spike-and-wave discharges), which can be differentiated by the focal versus generalized distribution of epileptiform discharges. An EEG in Rolandic epilepsy, however, reveals focal spikes in the centrotemporal region. First-line management for Rolandic epilepsy is often conservative, as many children experience spontaneous remission by adolescence. If treatment is required due to frequent or disruptive seizures, first-line AEDs such as levetiracetam or carbamazepine may be used. In pregnant adolescents or lactating mothers, the emphasis remains on selecting AEDs with a favorable safety profile. The benign nature of this syndrome generally means that aggressive therapy is not necessary. The marked answer, 'Centrotemporal (rolandic) spikes,' accurately reflects the EEG hallmark of Rolandic epilepsy. Other options like generalized spike-and-wave discharges (indicative of absence epilepsy), temporal lobe spikes (seen in temporal lobe epilepsy), or normal EEG findings, would be incorrect in this context. 1. Rolandic epilepsy is often benign and self-limited, with most children outgrowing the condition by puberty. 2. EEG in Rolandic epilepsy is characterized by high-amplitude centrotemporal spikes that are most prominent during non-REM sleep. 3. Differential diagnosis should carefully consider other pediatric epilepsy syndromes with distinct EEG patterns. Recent pediatric neurology guidelines emphasize the use of EEG as a key diagnostic tool for epilepsy syndromes, with high-resolution digital EEG now permitting more precise localization of epileptiform discharges. Ongoing research continues to support conservative management in most cases of Rolandic epilepsy while recognizing the need for individualized treatment when seizures are frequent or disabling.",
    "exam_year": "2018",
    "exam_type": "Part I",
    "image_url": "page_23.png"
  },
  {
    "question": "Scenario of mesiotemporal epilepsy (typical semiology) and ask about the diagnosis",
    "option_a": "is correct because it aligns with the classic semiology of mesiotemporal epilepsy. Option B (generalized epilepsy) is incorrect due to the absence of focal auras and automatisms in true generalized seizures. Option C (neocortical temporal epilepsy) is ruled out as its semiology can include sensory or language deficits rather than a typical epigastric aura. Option D (psychogenic non",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "(frontal lobe epilepsy) is also excluded due to its distinct presentation with brief, often hypermotor seizures usually occurring during sleep.",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Mesiotemporal epilepsy is a focal epilepsy syndrome that arises from the medial (mesial) structures of the temporal lobe\u2014primarily the hippocampus, amygdala, and parahippocampal regions. Its clinical semiology is characterized by specific auras (for example, an epigastric sensation), impaired awareness, and automatisms, which differentiate it from other forms of epilepsy. The condition is most often linked to structural and histopathological changes, such as hippocampal sclerosis. Abnormal neuronal excitability in the mesial temporal lobe initiates a focal seizure that may secondarily generalize. Current neuroimaging techniques (MRI) and video\u2011EEG studies confirm the focal nature of the discharges originating in these regions. Patients typically experience an epigastric aura (a rising sensation in the abdomen), followed by impaired awareness and often repetitive automatisms (such as lip smacking). These features help distinguish mesiotemporal epilepsy from epilepsies of generalized or other focal origins. The diagnosis relies on detailed clinical history, video-EEG monitoring that captures the characteristic ictal discharges, and high-resolution MRI to identify mesial temporal pathology (e.g., sclerosis). Differential diagnoses include generalized epilepsy (which lacks a focal aura), neocortical temporal epilepsy (which may present with lateralizing sensory or language disturbances), psychogenic non\u2010epileptic seizures (which usually show variable semiology and non-epileptic EEG findings), and frontal lobe epilepsy (often presenting with brief, hypermotor seizures). Management typically involves antiepileptic drugs (AEDs) such as lamotrigine, levetiracetam, and carbamazepine. In patients with medically refractory seizures, surgical interventions like anterior temporal lobectomy may be considered. Although this question is diagnostic, treatment strategies follow current epilepsy guidelines emphasizing individualized treatment based on seizure control and side-effect profiles. Option A is correct because it aligns with the classic semiology of mesiotemporal epilepsy. Option B (generalized epilepsy) is incorrect due to the absence of focal auras and automatisms in true generalized seizures. Option C (neocortical temporal epilepsy) is ruled out as its semiology can include sensory or language deficits rather than a typical epigastric aura. Option D (psychogenic non-epileptic seizures) is incorrect because the stereotyped, consistent EEG and clinical findings do not support a psychogenic origin. Option E (frontal lobe epilepsy) is also excluded due to its distinct presentation with brief, often hypermotor seizures usually occurring during sleep. 1) An epigastric aura is highly suggestive of mesiotemporal epilepsy. 2) Video-EEG monitoring remains the gold standard for localizing seizure onset. 3) Hippocampal sclerosis is a common structural abnormality in this condition. Recent guidelines emphasize the use of detailed neuroimaging and prolonged video-EEG monitoring for precise localization. Advances in surgical treatments, including minimally invasive techniques, have shown improved outcomes in patients with medically refractory mesiotemporal epilepsy.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Patient has epilepsy and she wants to get pregnant, which of the following statements is correct?",
    "option_a": "Lamotrigine clearance will increase in the first and second trimester",
    "option_b": "Levetiracetam is the safest AED",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "In women with epilepsy planning pregnancy, the management of antiepileptic drugs (AEDs) must balance effective seizure control with minimization of fetal risk. Understanding how physiological changes during pregnancy affect drug pharmacokinetics is crucial. Pregnancy induces significant physiological changes including an increased plasma volume, enhanced renal clearance, and increased activity of hepatic enzymes. In particular, lamotrigine is subject to increased metabolism during pregnancy, which results in decreased serum levels and may predispose to breakthrough seizures if the dose is not adjusted. The clinical implication is that a pregnant patient on lamotrigine may experience reduced drug efficacy as the pregnancy progresses, typically during the first and second trimesters. Regular therapeutic drug monitoring is key to maintaining effective concentrations. Evaluation of a pregnant woman with epilepsy includes assessing seizure control and monitoring serum levels of lamotrigine. Differential considerations include suboptimal adherence versus pharmacokinetic changes induced by pregnancy. Adjustments are based on serial blood levels and clinical status. First-line management involves maintaining seizure control while ensuring that drug levels remain therapeutic. For lamotrigine, dose adjustments are typically required during pregnancy due to increased clearance. Second-line strategies involve adding or switching AEDs if necessary. Pregnancy and lactation considerations include using medications with lower teratogenic risk, close monitoring, and counseling regarding potential dose adjustments during both pregnancy and the postpartum period. Current guidelines recommend individualized therapeutic drug monitoring throughout pregnancy. Option A is correct because lamotrigine clearance is known to increase during the first and second trimesters, necessitating dose adjustments to maintain therapeutic levels. Option B, which claims that levetiracetam is the safest AED, is overly simplistic; while levetiracetam is also considered safe, both lamotrigine and levetiracetam are preferred and the statement does not address the pharmacokinetic changes that occur with lamotrigine specifically. 1) Lamotrigine levels decrease during pregnancy, making regular monitoring crucial. 2) Preconception counseling is essential for optimizing seizure control and minimizing fetal risks. 3) Both lamotrigine and levetiracetam are favored in pregnancy due to their relatively low teratogenic risk. Recent research and updated guidelines underscore the importance of therapeutic drug monitoring for lamotrigine during pregnancy. Newer studies have provided further evidence on the altered pharmacokinetics in pregnant patients, guiding more precise dosing recommendations.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Multiple seizure types with intellectual impairment, what you will see in EEG?",
    "option_a": "Slow spike/wave less than 2Hz",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "The presentation of multiple seizure types associated with intellectual impairment is highly suggestive of an epileptic encephalopathy, particularly Lennox-Gastaut syndrome (LGS). A hallmark of LGS is its distinctive EEG pattern. LGS is characterized by widespread cortical dysfunction leading to a variety of seizure types \u2014 including tonic, atonic, and atypical absence seizures. The fundamental abnormality is a persistent disorganization of cerebral electrical activity, which is reflected in the slow spike-and-wave discharges observed on EEG. Patients with LGS typically present during childhood with multiple seizure types and cognitive impairment. The classic EEG finding of slow spike\u2010wave patterns (usually less than 2 Hz) is key to the diagnosis. Diagnosis is achieved via a combination of clinical history, detailed seizure semiology, and EEG findings. Differential diagnoses include other epileptic encephalopathies such as Dravet syndrome; however, the EEG pattern in LGS (slow spike-and-wave complexes) helps differentiate it from other conditions that may exhibit different EEG characteristics. Management of LGS is challenging. First-line AEDs include valproate, lamotrigine, and topiramate. Additional medications such as rufinamide and clobazam may be used as second-line or adjunctive therapy. For patients who are refractory to medications, non-pharmacologic interventions such as the ketogenic diet or vagus nerve stimulation (VNS) may be considered. In the context of pregnancy, treatment choices must be balanced against teratogenic risks (for instance, valproate is generally avoided), making careful selection and dosing essential. Option A is correct because a slow spike-and-wave pattern of less than 2 Hz is the classic EEG feature of Lennox-Gastaut syndrome. There is strong consensus in the literature and clinical practice supporting this finding as a key diagnostic criterion. 1) LGS is one of the most pharmacoresistant forms of epilepsy, often requiring a multimodal treatment approach. 2) The EEG hallmark of LGS is a slow (<2 Hz) spike-and-wave discharge pattern. 3) Early recognition is crucial for initiating appropriate supportive and therapeutic measures. Recent guidelines and studies reinforce the unique EEG patterns associated with LGS and are constantly evaluating novel therapies (including newer AEDs and non-pharmacological treatments) to improve seizure control and quality of life in these patients.",
    "exam_year": "2018",
    "exam_type": "Part I",
    "image_url": "page_19.png"
  },
  {
    "question": "Patient with HIV on HAART developed seizures, what is the most likely cause?",
    "option_a": "Efavirenz",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "In patients with HIV on highly active antiretroviral therapy (HAART) who develop seizures, it\u2019s essential to differentiate whether the seizures are due to opportunistic infections, metabolic derangements, or drug-induced neurotoxicity. One recognized cause within HAART regimens is medication-related adverse effects. Efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is known to have central nervous system (CNS) penetration and can cause neuropsychiatric side effects due to its direct neurotoxicity. In some patients, especially those with genetic variants affecting drug metabolism or with other pharmacokinetic predispositions, efavirenz may lower the seizure threshold, resulting in seizures. A patient on a HAART regimen containing efavirenz who develops seizures is likely experiencing a drug-induced neurotoxic effect rather than a complication from opportunistic infections. The timing of seizure onset in relation to initiating or adjusting the dose of efavirenz is an important clinical clue. The evaluation involves a detailed review of the medication regimen and timing of symptoms, neuroimaging to exclude CNS infections (e.g., toxoplasmosis, cryptococcal meningitis), and sometimes serum drug level monitoring. Differential diagnosis includes other causes of seizures in HIV such as metabolic abnormalities, primary seizure disorders, or opportunistic infections. Management of efavirenz-induced seizures entails reviewing and possibly modifying the antiretroviral regimen. If efavirenz is implicated, a switch to an alternative medication with a lower neurotoxic profile may be indicated. Alongside this, standard antiepileptic therapies are employed to control seizures. In pregnant and lactating patients, avoiding medications with high neurotoxicity is crucial, and alternative HAART regimens with better safety profiles are preferred as per current HIV treatment guidelines. Option A is correct as efavirenz is well documented to produce neuropsychiatric side effects, including the potential to induce seizures in susceptible individuals. Other potential options (not provided) are less commonly implicated in seizure induction within the HAART regimen. 1) Always review the antiretroviral regimen in an HIV patient presenting with new-onset seizures to exclude medication-related causes. 2) Efavirenz is notorious for CNS side effects, which can range from vivid dreams to frank seizures. 3) Neuroimaging and thorough work-up are essential to exclude opportunistic infections. Recent studies have focused on the genetic polymorphisms that affect efavirenz metabolism, which may predispose certain patients to higher plasma levels and increased neurotoxicity. Updated HIV management guidelines now suggest consideration of patient-specific factors when choosing HAART regimens, particularly in individuals with preexisting neurological conditions.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Patient has aphasia and multiple seizure types, what is the diagnosis?",
    "option_a": "Landau Kleffner Syndrome",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Landau\u2010Kleffner syndrome is a rare pediatric epileptic encephalopathy characterized by the loss of previously acquired language (aphasia) and various types of seizures. It usually affects children after a period of normal language development, leading to sudden language regression. The syndrome is believed to be due to abnormal epileptiform discharges, predominantly in the temporal regions, which interfere with the brain\u2019s language networks. Ongoing subclinical seizures or continuous spike\u2010wave discharges, particularly during sleep, disrupt normal language acquisition and processing. Children with Landau\u2010Kleffner syndrome present with aphasia (especially receptive language deficits) along with multiple seizure types (which may include focal seizures with or without secondary generalization). The clinical picture often includes language deterioration over weeks to months, often noticed by parents and teachers. Diagnosis is based on a detailed clinical history and EEG findings. Typical EEG findings include epileptiform discharges that are most prominent during sleep and often localized to the temporal lobes. Differential diagnoses include other childhood epileptic encephalopathies and conditions causing language regression (e.g., autism spectrum disorders), but the combination of acquired aphasia and epileptiform EEG changes is characteristic. Management includes antiepileptic drugs (AEDs) such as valproate, benzodiazepines, or even steroids in some cases, aiming to control seizures and possibly improve language outcome. Adjunctive speech and language therapy are essential. Although pregnancy and lactation considerations are less applicable in the pediatric population, in older females with epilepsy similar careful selection of AEDs (with drugs like lamotrigine or levetiracetam that have a better reproductive profile) is recommended in current guidelines. Option A (Landau Kleffner Syndrome) correctly fits the clinical picture of acquired aphasia and multiple seizure types in a child. The other options are not provided but would likely represent other forms of epileptic syndromes that do not display the specific pattern of language regression seen in Landau Kleffner syndrome. 1. A child with a history of normal language development who suddenly loses language skills should prompt evaluation for Landau\u2010Kleffner syndrome. 2. EEGs, especially during sleep, are critical for detecting the characteristic epileptiform discharges. 3. Early initiation of both AEDs and speech therapy may improve long\u2010term outcomes. Recent research emphasizes early recognition and aggressive management to limit language deterioration. Emerging evidence supports the use of steroids and immunomodulatory therapies in refractory cases, although controlled trials are still needed to standardize such treatments.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Patient on lamotrigine and wants to start OCP, what you will tell the patient?",
    "option_a": "OCP effect might be affected",
    "option_b": "She needs to increase the dose of lamotrigine by 2 folds",
    "option_c": "She needs to increase the dose of lamotrigine by 4 folds",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Landau\u2010Kleffner syndrome is a rare pediatric epileptic encephalopathy characterized by the loss of previously acquired language (aphasia) and various types of seizures. It usually affects children after a period of normal language development, leading to sudden language regression. The syndrome is believed to be due to abnormal epileptiform discharges, predominantly in the temporal regions, which interfere with the brain\u2019s language networks. Ongoing subclinical seizures or continuous spike\u2010wave discharges, particularly during sleep, disrupt normal language acquisition and processing. Children with Landau\u2010Kleffner syndrome present with aphasia (especially receptive language deficits) along with multiple seizure types (which may include focal seizures with or without secondary generalization). The clinical picture often includes language deterioration over weeks to months, often noticed by parents and teachers. Diagnosis is based on a detailed clinical history and EEG findings. Typical EEG findings include epileptiform discharges that are most prominent during sleep and often localized to the temporal lobes. Differential diagnoses include other childhood epileptic encephalopathies and conditions causing language regression (e.g., autism spectrum disorders), but the combination of acquired aphasia and epileptiform EEG changes is characteristic. Management includes antiepileptic drugs (AEDs) such as valproate, benzodiazepines, or even steroids in some cases, aiming to control seizures and possibly improve language outcome. Adjunctive speech and language therapy are essential. Although pregnancy and lactation considerations are less applicable in the pediatric population, in older females with epilepsy similar careful selection of AEDs (with drugs like lamotrigine or levetiracetam that have a better reproductive profile) is recommended in current guidelines. Option A (Landau Kleffner Syndrome) correctly fits the clinical picture of acquired aphasia and multiple seizure types in a child. The other options are not provided but would likely represent other forms of epileptic syndromes that do not display the specific pattern of language regression seen in Landau Kleffner syndrome. 1. A child with a history of normal language development who suddenly loses language skills should prompt evaluation for Landau\u2010Kleffner syndrome. 2. EEGs, especially during sleep, are critical for detecting the characteristic epileptiform discharges. 3. Early initiation of both AEDs and speech therapy may improve long\u2010term outcomes. Recent research emphasizes early recognition and aggressive management to limit language deterioration. Emerging evidence supports the use of steroids and immunomodulatory therapies in refractory cases, although controlled trials are still needed to standardize such treatments.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Scenario of Panayiotopoulos Syndrome, ask about the diagnosis\n\nIdiopathic susceptibility to early onset benign childhood seizures with electrographic occipital or extra occipital spikes, and manifest mainly with autonomic seizures, large independent studies have accumulated impressively, concordant information on the clinical and electrographic features of this syndrome.",
    "option_a": "(Landau Kleffner Syndrome) correctly fits the clinical picture of acquired aphasia and multiple seizure types in a child. The other options are not provided but would likely represent other forms of epileptic syndromes that do not display the specific pattern of language regression seen in Landau Kleffner syndrome.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Landau\u2010Kleffner syndrome is a rare pediatric epileptic encephalopathy characterized by the loss of previously acquired language (aphasia) and various types of seizures. It usually affects children after a period of normal language development, leading to sudden language regression. The syndrome is believed to be due to abnormal epileptiform discharges, predominantly in the temporal regions, which interfere with the brain\u2019s language networks. Ongoing subclinical seizures or continuous spike\u2010wave discharges, particularly during sleep, disrupt normal language acquisition and processing. Children with Landau\u2010Kleffner syndrome present with aphasia (especially receptive language deficits) along with multiple seizure types (which may include focal seizures with or without secondary generalization). The clinical picture often includes language deterioration over weeks to months, often noticed by parents and teachers. Diagnosis is based on a detailed clinical history and EEG findings. Typical EEG findings include epileptiform discharges that are most prominent during sleep and often localized to the temporal lobes. Differential diagnoses include other childhood epileptic encephalopathies and conditions causing language regression (e.g., autism spectrum disorders), but the combination of acquired aphasia and epileptiform EEG changes is characteristic. Management includes antiepileptic drugs (AEDs) such as valproate, benzodiazepines, or even steroids in some cases, aiming to control seizures and possibly improve language outcome. Adjunctive speech and language therapy are essential. Although pregnancy and lactation considerations are less applicable in the pediatric population, in older females with epilepsy similar careful selection of AEDs (with drugs like lamotrigine or levetiracetam that have a better reproductive profile) is recommended in current guidelines. Option A (Landau Kleffner Syndrome) correctly fits the clinical picture of acquired aphasia and multiple seizure types in a child. The other options are not provided but would likely represent other forms of epileptic syndromes that do not display the specific pattern of language regression seen in Landau Kleffner syndrome. 1. A child with a history of normal language development who suddenly loses language skills should prompt evaluation for Landau\u2010Kleffner syndrome. 2. EEGs, especially during sleep, are critical for detecting the characteristic epileptiform discharges. 3. Early initiation of both AEDs and speech therapy may improve long\u2010term outcomes. Recent research emphasizes early recognition and aggressive management to limit language deterioration. Emerging evidence supports the use of steroids and immunomodulatory therapies in refractory cases, although controlled trials are still needed to standardize such treatments.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Occipital seizure and migraine with aura, what is in favor of visual aura?",
    "option_a": "Circular coloring",
    "option_b": "Typical migraine headache",
    "option_c": "Scintillating",
    "option_d": "30s-1 min in duration",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Landau\u2010Kleffner syndrome is a rare pediatric epileptic encephalopathy characterized by the loss of previously acquired language (aphasia) and various types of seizures. It usually affects children after a period of normal language development, leading to sudden language regression. The syndrome is believed to be due to abnormal epileptiform discharges, predominantly in the temporal regions, which interfere with the brain\u2019s language networks. Ongoing subclinical seizures or continuous spike\u2010wave discharges, particularly during sleep, disrupt normal language acquisition and processing. Children with Landau\u2010Kleffner syndrome present with aphasia (especially receptive language deficits) along with multiple seizure types (which may include focal seizures with or without secondary generalization). The clinical picture often includes language deterioration over weeks to months, often noticed by parents and teachers. Diagnosis is based on a detailed clinical history and EEG findings. Typical EEG findings include epileptiform discharges that are most prominent during sleep and often localized to the temporal lobes. Differential diagnoses include other childhood epileptic encephalopathies and conditions causing language regression (e.g., autism spectrum disorders), but the combination of acquired aphasia and epileptiform EEG changes is characteristic. Management includes antiepileptic drugs (AEDs) such as valproate, benzodiazepines, or even steroids in some cases, aiming to control seizures and possibly improve language outcome. Adjunctive speech and language therapy are essential. Although pregnancy and lactation considerations are less applicable in the pediatric population, in older females with epilepsy similar careful selection of AEDs (with drugs like lamotrigine or levetiracetam that have a better reproductive profile) is recommended in current guidelines. Option A (Landau Kleffner Syndrome) correctly fits the clinical picture of acquired aphasia and multiple seizure types in a child. The other options are not provided but would likely represent other forms of epileptic syndromes that do not display the specific pattern of language regression seen in Landau Kleffner syndrome. 1. A child with a history of normal language development who suddenly loses language skills should prompt evaluation for Landau\u2010Kleffner syndrome. 2. EEGs, especially during sleep, are critical for detecting the characteristic epileptiform discharges. 3. Early initiation of both AEDs and speech therapy may improve long\u2010term outcomes. Recent research emphasizes early recognition and aggressive management to limit language deterioration. Emerging evidence supports the use of steroids and immunomodulatory therapies in refractory cases, although controlled trials are still needed to standardize such treatments.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "question": "Patient came with focal seizure progress to complex partial seizures and multiple status epilepticus with hemi weakness MRI showed hemispheric perisylvian atrophy what will you send for?",
    "option_a": "Glur3 antibody",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "This scenario is classic for Rasmussen encephalitis \u2013 a chronic, progressive unilateral encephalitis that typically presents with focal seizures (which may evolve into complex partial seizures) and progressive neurological deficits such as hemiparesis. The MRI finding of hemispheric perisylvian atrophy further supports this diagnosis, and historically, anti\u2010GluR3 antibodies have been associated with the disease. Rasmussen encephalitis is believed to be an immune-mediated disorder. T-cell\u2013mediated destruction of neurons, along with the involvement of auto-antibodies such as anti\u2013GluR3, contributes to ongoing inflammation and subsequent hemispheric atrophy. Although the exact pathogenic role of GluR3 antibodies remains debated, they have been classically linked to the excitotoxicity and inflammatory damage observed in this condition. Patients generally present with drug-resistant focal seizures, which may progress to status epilepticus, and develop progressive hemiparesis and cognitive decline. The focal neurological deficits correlate directly with localized inflammation and atrophy seen on MRI. In children, early identification and treatment are critical to limit neurological deterioration. Diagnosis is based on the combination of clinical history, characteristic unilateral seizure onset with progressive neurological deficits, and radiologic findings (such as hemispheric atrophy especially in perisylvian regions). Differential diagnoses include Sturge-Weber syndrome and other causes of unilateral cortical atrophy (e.g., post-encephalitic changes), but the progressive course with refractory seizures makes Rasmussen encephalitis most likely. Ancillary testing may include EEG (showing unilateral epileptiform discharges) and, in some cases, immunological testing for antibodies. Management is tiered. First-line treatments include immunomodulatory therapies such as high-dose corticosteroids, IV immunoglobulin (IVIG), and plasmapheresis, aimed at reducing the inflammatory process. If seizures remain refractory and neurological deficits progress, functional hemispherectomy may be considered. In the context of pregnancy or lactation, the choice of immunosuppressive therapies and antiepileptic drugs (AEDs) requires careful risk\u2013benefit analysis to minimize teratogenic effects; counseling and folate supplementation are essential if AEDs with known teratogenic potential are used. Option A (GluR3 antibody) is correct because it aligns with the classical association of anti\u2013GluR3 antibodies with Rasmussen encephalitis. The other options are not provided, which reinforces that the test is focusing on this immunological marker. 1. Rasmussen encephalitis typically presents with unilateral, drug\u2010resistant focal seizures and progressive hemiparesis. 2. MRI findings of unilateral perisylvian atrophy support the diagnosis. 3. Early immunomodulatory therapy may help slow disease progression. Recent research continues to explore the T-cell\u2013mediated mechanisms and the role of autoantibodies (including anti\u2013GluR3) in Rasmussen encephalitis. While the exact pathogenic role of these antibodies is still under evaluation, immunotherapy remains the cornerstone of management, and emerging studies focus on optimizing early intervention strategies.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "question": "Patient with features of Rolandic epilepsy what is the EEG finding.",
    "option_a": "Continue spike and wave during sleeping.",
    "option_b": "Central sharp wave in the mid temporal area.",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "This scenario is classic for Rasmussen encephalitis \u2013 a chronic, progressive unilateral encephalitis that typically presents with focal seizures (which may evolve into complex partial seizures) and progressive neurological deficits such as hemiparesis. The MRI finding of hemispheric perisylvian atrophy further supports this diagnosis, and historically, anti\u2010GluR3 antibodies have been associated with the disease. Rasmussen encephalitis is believed to be an immune-mediated disorder. T-cell\u2013mediated destruction of neurons, along with the involvement of auto-antibodies such as anti\u2013GluR3, contributes to ongoing inflammation and subsequent hemispheric atrophy. Although the exact pathogenic role of GluR3 antibodies remains debated, they have been classically linked to the excitotoxicity and inflammatory damage observed in this condition. Patients generally present with drug-resistant focal seizures, which may progress to status epilepticus, and develop progressive hemiparesis and cognitive decline. The focal neurological deficits correlate directly with localized inflammation and atrophy seen on MRI. In children, early identification and treatment are critical to limit neurological deterioration. Diagnosis is based on the combination of clinical history, characteristic unilateral seizure onset with progressive neurological deficits, and radiologic findings (such as hemispheric atrophy especially in perisylvian regions). Differential diagnoses include Sturge-Weber syndrome and other causes of unilateral cortical atrophy (e.g., post-encephalitic changes), but the progressive course with refractory seizures makes Rasmussen encephalitis most likely. Ancillary testing may include EEG (showing unilateral epileptiform discharges) and, in some cases, immunological testing for antibodies. Management is tiered. First-line treatments include immunomodulatory therapies such as high-dose corticosteroids, IV immunoglobulin (IVIG), and plasmapheresis, aimed at reducing the inflammatory process. If seizures remain refractory and neurological deficits progress, functional hemispherectomy may be considered. In the context of pregnancy or lactation, the choice of immunosuppressive therapies and antiepileptic drugs (AEDs) requires careful risk\u2013benefit analysis to minimize teratogenic effects; counseling and folate supplementation are essential if AEDs with known teratogenic potential are used. Option A (GluR3 antibody) is correct because it aligns with the classical association of anti\u2013GluR3 antibodies with Rasmussen encephalitis. The other options are not provided, which reinforces that the test is focusing on this immunological marker. 1. Rasmussen encephalitis typically presents with unilateral, drug\u2010resistant focal seizures and progressive hemiparesis. 2. MRI findings of unilateral perisylvian atrophy support the diagnosis. 3. Early immunomodulatory therapy may help slow disease progression. Recent research continues to explore the T-cell\u2013mediated mechanisms and the role of autoantibodies (including anti\u2013GluR3) in Rasmussen encephalitis. While the exact pathogenic role of these antibodies is still under evaluation, immunotherapy remains the cornerstone of management, and emerging studies focus on optimizing early intervention strategies.",
    "exam_year": "2019",
    "exam_type": "Part I",
    "image_url": "page_25.png"
  },
  {
    "question": "Patient with hyperkinetic nocturnal seizure with positive family history how would you treat him",
    "option_a": "Carbamazepine",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "This scenario is classic for Rasmussen encephalitis \u2013 a chronic, progressive unilateral encephalitis that typically presents with focal seizures (which may evolve into complex partial seizures) and progressive neurological deficits such as hemiparesis. The MRI finding of hemispheric perisylvian atrophy further supports this diagnosis, and historically, anti\u2010GluR3 antibodies have been associated with the disease. Rasmussen encephalitis is believed to be an immune-mediated disorder. T-cell\u2013mediated destruction of neurons, along with the involvement of auto-antibodies such as anti\u2013GluR3, contributes to ongoing inflammation and subsequent hemispheric atrophy. Although the exact pathogenic role of GluR3 antibodies remains debated, they have been classically linked to the excitotoxicity and inflammatory damage observed in this condition. Patients generally present with drug-resistant focal seizures, which may progress to status epilepticus, and develop progressive hemiparesis and cognitive decline. The focal neurological deficits correlate directly with localized inflammation and atrophy seen on MRI. In children, early identification and treatment are critical to limit neurological deterioration. Diagnosis is based on the combination of clinical history, characteristic unilateral seizure onset with progressive neurological deficits, and radiologic findings (such as hemispheric atrophy especially in perisylvian regions). Differential diagnoses include Sturge-Weber syndrome and other causes of unilateral cortical atrophy (e.g., post-encephalitic changes), but the progressive course with refractory seizures makes Rasmussen encephalitis most likely. Ancillary testing may include EEG (showing unilateral epileptiform discharges) and, in some cases, immunological testing for antibodies. Management is tiered. First-line treatments include immunomodulatory therapies such as high-dose corticosteroids, IV immunoglobulin (IVIG), and plasmapheresis, aimed at reducing the inflammatory process. If seizures remain refractory and neurological deficits progress, functional hemispherectomy may be considered. In the context of pregnancy or lactation, the choice of immunosuppressive therapies and antiepileptic drugs (AEDs) requires careful risk\u2013benefit analysis to minimize teratogenic effects; counseling and folate supplementation are essential if AEDs with known teratogenic potential are used. Option A (GluR3 antibody) is correct because it aligns with the classical association of anti\u2013GluR3 antibodies with Rasmussen encephalitis. The other options are not provided, which reinforces that the test is focusing on this immunological marker. 1. Rasmussen encephalitis typically presents with unilateral, drug\u2010resistant focal seizures and progressive hemiparesis. 2. MRI findings of unilateral perisylvian atrophy support the diagnosis. 3. Early immunomodulatory therapy may help slow disease progression. Recent research continues to explore the T-cell\u2013mediated mechanisms and the role of autoantibodies (including anti\u2013GluR3) in Rasmussen encephalitis. While the exact pathogenic role of these antibodies is still under evaluation, immunotherapy remains the cornerstone of management, and emerging studies focus on optimizing early intervention strategies.",
    "exam_year": "2019",
    "exam_type": "Part I"
  }
]